Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease". - Gleason AM; Tayebi N; Lopez GJ; Sidransky E (Movement disorders : official journal of the Movement Disorder Society, 2022)